Preliminary Data Shows How TMS May Treat Depressive Symptoms in Patients with Multiple Sclerosis
Read about how Transcranial Magnetic Stimulation (TMS) may help with the depressive symptoms that patients with multiple sclerosis experience.
Depression is a leading cause of disability for adults aged 15-44 in the United States. Fortuantely, there are many treatments and therapy that are available to individuals experiencing this condition. Transcranial magnetic stimulation (TMS) is an FDA approved treatment for treatment resistant depression. However, the magnetic stimulation from TMS also has other off label uses that can be used to alleviate and/or treat other illnesses as well.
Ongoing, yet promising research continued with TMS use for other conditions. It is studied extensively across disorder and even disciplines with the hope that it could advance treatments for neurological disorder, pain management, and physical rehabilitation along with psychiatry. There are currently ongoing large clinical studies investigating the effectiveness of TMS in conditions such a generalized anxiety disorder, post traumatic stress disorder, pediatric depression, bipolar disorder, smoking cessation, chronic pain, and obsessive-compulsive disorder. While these treatments have not been FDA approved, there are plenty of scientific-backed evidence that TMS use to treat these disorders are effective.
Here is a list of peer reviewed articles for the appropriate condition:
